Ola Nilsson
Head of Neoantigen Development at NEOGAP Therapeutics AB- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
Engelska -
Topline Score
Bio
Credentials
-
NEOGAP LEADERSHIP PROGRAM
ChefakademinFeb, 2023- Sep, 2024
Experience
-
NEOGAP Therapeutics AB
-
Sweden
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Head of Neoantigen Development
-
Apr 2022 - Present
In the role as Head of Neoantigen Development at NEOGAP Therapeutics AB, I lead a team that focuses on Research, Development and Production of Neoantigens. The Neoantigens are currently manufactured as a raw material, EpiTCer® beads, which are part of a personalised advanced therapy medicinal product (ATMP). Since the company was founded, I have been involved in the scientific development of the EpiTCer® beads technology employed by the company to treat cancer.The production process involves bioinformatics analysis of Next-generation sequencing data using a validated in-house developed computerised system, PIOR®, where I am appointed System Owner and Product Owner. The production process for EpiTCer® beads also involves recombinant protein production and aseptic processing during the final production steps.As Production Manager for EpiTCer® beads, I have also been involved in the work to set up the Quality Management System (QMS) employed at NEOGAP Therapeutics AB.
-
-
Bioengineering Manager
-
Mar 2020 - Mar 2022
In the role as Bioengineering Manager at NEOGAP Therapeutics AB (formerly TCER AB), I participate in the work to establish a production process to manufacture raw materials, which are part of a personalised advanced therapy medicinal product (ATMP). Since the company was founded, I have been involved in the scientific development of the EpiTCer beads technology employed by the company to treat cancer.As Bioengineering Manager, I am appointed Production Manager for the manufacturing of EpiTCer beads. The production process involves bioinformatics analysis of Next-generation sequencing data using an in-house developed computerised system, where I am appointed System Owner and Product Owner. The system is validated according to applicable parts of GAMP5, where I am appointed validation leader. The production process for EpiTCEer beads also involves recombinant protein production and aseptic processing during the final production steps.As Production Manager, I am involved in the work to set up the Quality Management System (QMS) employed at NEOGAP Therapeutics AB, used in the production of EpiTCer beads. I am also involved in the preparation of supporting documentation for Investigational Medicinal Product Dossier (IMPD) and Investigator's Brochure (IB).
-
-
-
TCER AB
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Principal research scientist – Biotechnology & Quality Assurance
-
Nov 2016 - Feb 2020
Design, production and quality assurance of recombinant biologicals. Establishment of novel SOPs for the production of protein molecules to be used therapeutically in accordance with regulatory requirements. Method development and implementation in clinical trial. Design, production and quality assurance of recombinant biologicals. Establishment of novel SOPs for the production of protein molecules to be used therapeutically in accordance with regulatory requirements. Method development and implementation in clinical trial.
-
-
-
Stockholm University
-
Sweden
-
Research Services
-
700 & Above Employee
-
Postdoc
-
Sep 2012 - Oct 2016
Post doctoral research fellow in the group of professor Gunnar von Heijne at Stockholm University. Studies in the area of co-translational protein folding, characterizing nascent chain folding at the ribosomal exit tunnel. Post doctoral research fellow in the group of professor Gunnar von Heijne at Stockholm University. Studies in the area of co-translational protein folding, characterizing nascent chain folding at the ribosomal exit tunnel.
-
-
-
Karolinska Institutet
-
Sweden
-
Higher Education
-
700 & Above Employee
-
PhD student
-
Mar 2008 - Jun 2012
Allergy diagnostics and vaccine development at Karolinska Institutet. Allergy diagnostics and vaccine development at Karolinska Institutet.
-
-
Education
-
2008 - 2012
Karolinska institutet
Doctor of Philosophy (Ph.D.), Medicin -
2003 - 2007
Karolinska institutet
Master of Science (M.Sc.), Biomedicin -
2005 - 2005
Leiden University Medical Center
Community
